PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Randox Laboratories Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Randox Laboratories Ltd Unveils New Liquid Quality Control - 'Randox Acusera' - The Randox Acusera range of quality control sera is set to expand with the introduction of our new liquid ready to use QC
Randox Laboratories Ltd Unveils New Liquid Quality Control - 'Randox Acusera'

 

NewswireToday - /newswire/ - Crumlin, Antrim, United Kingdom, 2010/02/11 - The Randox Acusera range of quality control sera is set to expand with the introduction of our new liquid ready to use QC.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Liquid controls eliminate the need for reconstitution minimising the risk of human error saving labs both time and money in the process.

As always with Randox the new range guarantees the same great performance and high quality as our existing controls. In fact Randox controls are well known to be of the highest quality and the most accurate, stable and consistent controls on the market.

Liquid stable controls will be available for:

• Clinical Chemistry
• Immunoassay
• Cardiac
• Blood Gas
• Urinalysis.

Unreliable performance can result in the misdiagnosis of patients and cause delays in treatment, the use of internal quality controls is therefore important not only in detecting errors within the lab but in providing patients with reliable results and the best possible care.

Randox can also provide customised quality control materials tailor made to fit customer specifications.

In addition to our extensive range of quality control materials Randox provide 24/7 an internet driven peer group reporting system and RIQAS, an external quality assurance scheme providing customers with 15 EQA programmes.

About Randox

• Randox (randox.com) is an international diagnostic solutions company, headquartered in the UK with 25 offices worldwide.
• Randox is a market leader in developing, manufacturing and marketing clinical diagnostic products including the revolutionary Biochip Array Technology, clinical chemistry analysers and reagents, quality controls and EQA as well as a complete life science range.
• Randox provides innovative products to over 30,000 customers worldwide ranging from hospitals and research laboratories to veterinary laboratories, pharmaceutical companies and crime labs.
• Re-invests significantly into Research and Development.
• 5 x Winners of the Queen’s Award for Enterprise.
- Invest NI Innovator of the Year 2009
- Manufacturing Excellence Award 2009 for Product Innovation
• Randox is revolutionising healthcare through continuously improving diagnostic solutions.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Randox Laboratories Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Randox Laboratories Ltd Unveils New Liquid Quality Control - 'Randox Acusera'

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Chris Henry - Randox.com 
+44(0)28 9442 2413 marketing[.]randox.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Randox Laboratories Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Randox Laboratories Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)